ABSTRACT:
A randomized, single-blind, placebo-controlled clinical trial, conducted in the Department of Dermatology and Venereology in Al-Kindy Teaching Hospital, Baghdad, Iraq for a duration of 19 months (from April 2017 to Nov. 2018) to assess the effectiveness of Topical vitamin K cream 1% in treatment of steroid-induced rosacea. The study involved 75 females diagnosed with steroid-induced rosacea of erythematotelangiectatic subtype. Total number of patients was 75 with mean age 37.1±3.022 years and the patients divided randomly into two groups. Group A was 25 patients received. Aqua soft cream twice daily for a period of two months. While group B was 50 patients were received topical vitamin K cream 1%. One questionnaire had been applied to all cases, full history and examination had been done. Patients in each group were assessed after 4 weeks and 8 weeks of therapy according to Erythematotelangiectatic severity scoring system regarding flushing, non-transient erythema, telangiectasia, burning and dryness. Results revealed that the mean of erythematotelangiectasia severity score was reduced in both groups but it was statistically significant in treated group. In vitamin K treated group the p-value was statistically significant after 4 weeks and it was highly significant after 8 weeks of therapy. We concluded that the use of topical vitamin K was effective therapeutics option in treatment of SIR with rapid improvement in the flushing, non-transient erythema, telangiectasia, burning and dryness with mild and tolerable side effects.
Cite this article:
Galawish Ahmed Abdullah. The Effectiveness of Topical Vitamin K Cream 1% in the Treatment of Steroid-Induced Rosacea. Research J. Pharm. and Tech. 2020; 13(8):3883-3886. doi: 10.5958/0974-360X.2020.00687.3
Cite(Electronic):
Galawish Ahmed Abdullah. The Effectiveness of Topical Vitamin K Cream 1% in the Treatment of Steroid-Induced Rosacea. Research J. Pharm. and Tech. 2020; 13(8):3883-3886. doi: 10.5958/0974-360X.2020.00687.3 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-8-60
REFERENCES:
1. Sulzberger MB, Witten VH, Yaffe SN. Cortisone acetate administered orally in dermatologic therapy. Arch Dermatol Syphilol. 1951; 64:573-78.
2. Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J. 1969;1:671-673.
3. Bhankharia DA, Sanjana PH. efficacy of desonide 0.05%cream and the lotion in steroid-responsive dermatoses in Indian patients: A post-marketing surveillance study. Indian J Dermatol Venereol Leprol. 2004;70:288-91.
4. Leyden S, Thew M, Kligman AM. Steroid Rosacea. Arch Dermatol 1974;110:619-22.
5. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol 2015; 72:761-70. https://doi.org/10.1016/j.jaad.2014.08.027.
6. Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol 2017;26:659-67. https://doi.org/10.1111/exd.13143.
7. Lanoue J, Goldenberg G. Therapies to improve the cosmetic symptoms of rosacea. Cutis 2015;96:19-26.
8. Tanghetti E, Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Eichenfield LF, American Acne and Rosacea Society. Consensus recommendations from the American Acne and Rosacea Society on the management of rosacea, part 4: a status report on the physical modalities and devices. Cutis 2014;93:71-6.
9. Elson ML, Nacht S. Treatment of periorbital hyperpigmentation with topical vitamin K/vitamin A. Cosmet Dermatol. 1999 Dec;12:27-127.
10. Elson ML, inventor; Mayapple Holdings LLC, assignee. Method of treating blood vessel disorders of the skin using vitamin K. United States patent US 1996 Apr 23 ;5:510.
11. Hemmati AA, Houshmand G, Ghorbanzadeh B, Nemati M, Behmanesh MA. Topical vitamin K1 promotes repair of full thickness wound in rat. Indian Journal of Pharmacology. 2014 Jul; 46(4):409.
12. Cohen JL, Bhatia AC. The role of topical vitamin K oxide gel in the resolution of post-procedural purpura. Journal Drugs Dermatol. 2009;8(11):1020-1024.
13. Sakamoto FH, Avram MM, Anderson RR. Lasers and Other Energy Technologies- Principles of Laser -Skin Interactions. Bolognia JL, Jorizzo JL, Shaffer JV, Editors. Elsevier 3rd ed. Spain : 2012 . p2251- 2259.
14. Wilkin J, Dahl M, Detmar M. National Rosacea Society Expert Committee. Standard grading system for rosacea : Report of the National. Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004 ; 50: 907–912.
15. Rathi SK, Kumrah L. Topical Corticosteroid induced rosacea like dermatitis: A clinical study of 110 cases. Indian J Dermatol Venereol Leprol. 2011; 77 : 42-6.
16. Dhalimi MA, Aljawahiry N. Misuse of topical corticosteroids: A clinical study in an Iraqi hospital. East Mediterr Health J. 2006;12:847-52.
17. Lu H, Xiao T, Lu B, Dong D, Yu D, Wei H and Chen HD: Facial corticosteroid addictive dermatitis in Guiyang City, China. Clin Exp Dermatol 2010; 35: 618-621.
18. Monika Pasikowska1, Renata Debowska1, Katarzyna Kisiel Rogiewicz, Irena Eris .A study of Vitamin K derivate improves condition of the skin with dilated capillaries .Dermatological Centre, Miedzyleski Hospital, Warsaw, Poland Dubai derma conference 2015;3:18.
19. Srisuttiyakorn C , Vathanasanti A., Kanechorn-Na-Ayuthaya A. The study of efficacy of topical vitamin k versus 5% urea cream on laser induced purpura. Clin Res Dermatol Open Access 2016, 3 (2) :1-3.
20. Lou WW, Quintana AT, Geronemus RG, Grossman MC. Effects of topical vitamin K and retinol on laser-induced purpura on non lesional skin. Dermatol Surg. 1999;25(12):942-944.
21. Shah NS, Lazarus MC, Bugdodel R, Hsia SL, He J, Duncan R. The effects of topical vitamin K in bruising after laser treatment. J Am Acad Dermatol. 2002; 47(2):241-244.
22. Srisuttiyakorn C, Vathanasanti A., Kanechorn-Na-Ayuthaya A. The study of efficacy of tropical vitamin K versus 5% urea cream on laser induced purpura. Clin Res Dermatol Open Access 2016, 3(2):1-3.